Anti-FHL2 Antibody

FHL2 (Four-and-a-Half LIM Domains Protein 2) is a LIM-only transcriptional coactivator widely studied in cardiovascular biology, cancer signaling, and skeletal muscle differentiation. This unconjugated polyclonal reagent from Antibodies.com is raised in rabbit and validated for western blot detection of endogenous FHL2 in human, mouse, and rat samples, supporting comparative studies across cell-line panels and primary tissue specimens.

Each vial contains 100 µl of protein A-purified antibody at 1 mg/ml, formulated in PBS with 0.1% sodium azide and 50% glycerol. The unconjugated format allows researchers to pair the reagent with standard HRP- or fluorophore-labeled secondary detection chemistries, and the glycerol-supplemented buffer can be diluted directly into blocking buffer for routine immunoblotting workflows. FHL2's documented role in transcriptional complex assembly, Rho-GTPase signaling, and androgen receptor co-regulation makes this antibody a practical choice for expression profiling, co-immunoprecipitation validation, and downstream pathway analyses.

For long-term stability, store the vial at -20 °C; aliquoting upon first use is recommended to limit freeze-thaw cycles. Supplied by Antibodies.com, the product is intended for research use only, with relevant validation data accessible through the supplier.